Catalyst Wire Dossier Catalyst Wire Dossier

18F-FAPI-04

Fluorine-18 labeled fibroblast activation protein inhibitor FAPI-04
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 18F-FAPI-04, covering 2024-08-16 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer

See pricing